Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health has disclosed Current Deferred Revenue across 8 years of filings, most recently posting $65.7 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $65.7 million, down 21.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.7 million (down 21.94% YoY), and the FY2025 annual result was $62.3 million, down 30.06% from the prior year.
• Current Deferred Revenue came in at $65.7 million for Q1 2026 at Teladoc Health, up from $62.3 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $121.6 million in Q2 2023 to a low of $62.3 million in Q4 2025.
• The 5-year median for Current Deferred Revenue is $107.2 million (2024), against an average of $97.2 million.
• Across the five-year window, Current Deferred Revenue jumped 50.55% in 2022 and plunged 30.31% in 2025, its largest moves.
• Teladoc Health's Current Deferred Revenue stood at $113.8 million in 2022, then declined by 3.96% to $109.3 million in 2023, then declined by 18.48% to $89.1 million in 2024, then plunged by 30.06% to $62.3 million in 2025, then advanced by 5.47% to $65.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $65.7 million (Q1 2026), $62.3 million (Q4 2025), and $70.1 million (Q3 2025), per Business Quant data.